| Line Item | 2026-03-29 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $150.4M | — | +26.3% |
| Cost of Revenue | $77.7M | — | +17.1% |
| Gross Profit | $72.7M | — | +37.8% |
| R&D Expense | $22.8M | — | +41.1% |
| SG&A Expense | $18.2M | — | +2.4% |
| Operating Income | $7.6M | — | +620.9% |
| Pre-tax Income | $15.3M | — | +4692.2% |
| Income Tax | $415K | — | -17.3% |
| Net Income | $14.9M | — | +1881.7% |
| EPS (Basic) | $0.14 | — | +1500.0% |
| EPS (Diluted) | $0.13 | — | +1400.0% |
| Line Item | 2026-03-29 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $152.6M | +4.2% | +81.7% |
| Accounts Receivable | $52.2M | +31.5% | +13.3% |
| Inventory | $44.0M | +6.7% | +27.2% |
| Current Assets | $275.7M | +5.8% | +11.9% |
| Total Assets | $360.2M | +16.0% | +21.5% |
| Current Liabilities | $181.7M |
| Line Item | 2026-03-29 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $27.9M | — | -9.9% |
| Investing Cash Flow | -$14.3M | — | +0.1% |
| Financing Cash Flow | -$7.3M | — | +49.7% |
| +4.8% |
| Total Liabilities | $200.8M | +9.9% | +3.9% |
| Stockholders' Equity | $159.4M | +24.7% | +54.2% |